-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G8akXiR3Ss0o0Xx+4UahVNfuRrYtJplUjZ0hn+z2Yvdaw9gebfKtzfDnp14QeO0q YH9Ql/aR9RVdXePD4dqNzA== 0001104659-07-016361.txt : 20070305 0001104659-07-016361.hdr.sgml : 20070305 20070305164258 ACCESSION NUMBER: 0001104659-07-016361 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070131 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20070305 DATE AS OF CHANGE: 20070305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellu Tissue Holdings, Inc. CENTRAL INDEX KEY: 0001295976 STANDARD INDUSTRIAL CLASSIFICATION: PAPER MILLS [2621] IRS NUMBER: 061346495 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-118829 FILM NUMBER: 07671728 BUSINESS ADDRESS: STREET 1: 3442 FRANCIS ROAD STREET 2: SUITE 220 CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: (678)393-2651 MAIL ADDRESS: STREET 1: 3442 FRANCIS ROAD STREET 2: SUITE 220 CITY: ALPHARETTA STATE: GA ZIP: 30004 8-K 1 a07-6897_28k.htm 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)      January 31, 2007

Cellu Tissue Holdings, Inc.
(Exact name of registrant as specified in its charter)

Delaware

 

333-118829

 

06-1346495

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

 

 

 

1855 Lockeway Drive, Suite 501

 

 

Alpharetta, Georgia

 

30004

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code      (678) 393-2651

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 5.02   Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Effective January 31, 2007, the Company’s sole shareholder, Cellu Paper, appointed Mr. Scott Bell to serve on its Board of Directors.

*****



 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cellu Tissue Holdings, Inc.

 

 

 

(Registrant)

 

 

 

 

 

 

 

Date: March 5, 2007

By:

/s/ Dianne M. Scheu

 

 

 

 

Ms. Dianne M. Scheu

 

 

 

 

Senior Vice President, Finance and

 

 

 

 

Chief Financial Officer

 

 

 

 


 -----END PRIVACY-ENHANCED MESSAGE-----